Global Long-acting Weight Loss Drugs Market Growth 2026-2032
The global Long-acting Weight Loss Drugs market size is predicted to grow from US$ 4836 million in 2025 to US$ 7522 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.
Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body"s metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It"s essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.
The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting Weight Loss Drugs Industry Forecast” looks at past sales and reviews total world Long-acting Weight Loss Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting Weight Loss Drugs sales for 2026 through 2032. With Long-acting Weight Loss Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Weight Loss Drugs industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Weight Loss Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting Weight Loss Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Weight Loss Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Weight Loss Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Weight Loss Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Weight Loss Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body"s metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It"s essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.
The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting Weight Loss Drugs Industry Forecast” looks at past sales and reviews total world Long-acting Weight Loss Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting Weight Loss Drugs sales for 2026 through 2032. With Long-acting Weight Loss Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Weight Loss Drugs industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Weight Loss Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting Weight Loss Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Weight Loss Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Weight Loss Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Weight Loss Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Weight Loss Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Orlistat
- Semaglutide
- Liraglutide
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Roche
- GSK
- Vivus
- Arena
- Orexigen
- What is the 10-year outlook for the global Long-acting Weight Loss Drugs market?
- What factors are driving Long-acting Weight Loss Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Long-acting Weight Loss Drugs market opportunities vary by end market size?
- How does Long-acting Weight Loss Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Weight Loss Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting Weight Loss Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting Weight Loss Drugs by Country/Region, 2021, 2025 & 2032
2.2 Long-acting Weight Loss Drugs Segment by Type
2.2.1 Orlistat
2.2.2 Semaglutide
2.2.3 Liraglutide
2.2.4 Other
2.2.5 Long-acting Weight Loss Drugs Sales by Type
2.2.5.1 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Long-acting Weight Loss Drugs Sale Price by Type (2021-2026)
2.3 Long-acting Weight Loss Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Long-acting Weight Loss Drugs Sales by Application
2.3.4.1 Global Long-acting Weight Loss Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Long-acting Weight Loss Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting Weight Loss Drugs Breakdown Data by Company
3.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting Weight Loss Drugs Sales Market Share by Company (2021-2026)
3.2 Global Long-acting Weight Loss Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting Weight Loss Drugs Revenue by Company (2021-2026)
3.2.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting Weight Loss Drugs Sale Price by Company
3.4 Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Weight Loss Drugs Product Location Distribution
3.4.2 Players Long-acting Weight Loss Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Weight Loss Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting Weight Loss Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting Weight Loss Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting Weight Loss Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting Weight Loss Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting Weight Loss Drugs Sales Growth
4.4 APAC Long-acting Weight Loss Drugs Sales Growth
4.5 Europe Long-acting Weight Loss Drugs Sales Growth
4.6 Middle East & Africa Long-acting Weight Loss Drugs Sales Growth
5 AMERICAS
5.1 Americas Long-acting Weight Loss Drugs Sales by Country
5.1.1 Americas Long-acting Weight Loss Drugs Sales by Country (2021-2026)
5.1.2 Americas Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
5.2 Americas Long-acting Weight Loss Drugs Sales by Type (2021-2026)
5.3 Americas Long-acting Weight Loss Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Weight Loss Drugs Sales by Region
6.1.1 APAC Long-acting Weight Loss Drugs Sales by Region (2021-2026)
6.1.2 APAC Long-acting Weight Loss Drugs Revenue by Region (2021-2026)
6.2 APAC Long-acting Weight Loss Drugs Sales by Type (2021-2026)
6.3 APAC Long-acting Weight Loss Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Weight Loss Drugs by Country
7.1.1 Europe Long-acting Weight Loss Drugs Sales by Country (2021-2026)
7.1.2 Europe Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
7.2 Europe Long-acting Weight Loss Drugs Sales by Type (2021-2026)
7.3 Europe Long-acting Weight Loss Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Weight Loss Drugs by Country
8.1.1 Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs
10.3 Manufacturing Process Analysis of Long-acting Weight Loss Drugs
10.4 Industry Chain Structure of Long-acting Weight Loss Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Weight Loss Drugs Distributors
11.3 Long-acting Weight Loss Drugs Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
12.1 Global Long-acting Weight Loss Drugs Market Size Forecast by Region
12.1.1 Global Long-acting Weight Loss Drugs Forecast by Region (2027-2032)
12.1.2 Global Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting Weight Loss Drugs Forecast by Type (2027-2032)
12.7 Global Long-acting Weight Loss Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.2.3 Roche Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.3.3 GSK Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Vivus
13.4.1 Vivus Company Information
13.4.2 Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.4.3 Vivus Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vivus Main Business Overview
13.4.5 Vivus Latest Developments
13.5 Arena
13.5.1 Arena Company Information
13.5.2 Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.5.3 Arena Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Arena Main Business Overview
13.5.5 Arena Latest Developments
13.6 Orexigen
13.6.1 Orexigen Company Information
13.6.2 Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.6.3 Orexigen Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Orexigen Main Business Overview
13.6.5 Orexigen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Weight Loss Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting Weight Loss Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting Weight Loss Drugs by Country/Region, 2021, 2025 & 2032
2.2 Long-acting Weight Loss Drugs Segment by Type
2.2.1 Orlistat
2.2.2 Semaglutide
2.2.3 Liraglutide
2.2.4 Other
2.2.5 Long-acting Weight Loss Drugs Sales by Type
2.2.5.1 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Long-acting Weight Loss Drugs Sale Price by Type (2021-2026)
2.3 Long-acting Weight Loss Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Long-acting Weight Loss Drugs Sales by Application
2.3.4.1 Global Long-acting Weight Loss Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Long-acting Weight Loss Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Long-acting Weight Loss Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting Weight Loss Drugs Breakdown Data by Company
3.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting Weight Loss Drugs Sales Market Share by Company (2021-2026)
3.2 Global Long-acting Weight Loss Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting Weight Loss Drugs Revenue by Company (2021-2026)
3.2.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting Weight Loss Drugs Sale Price by Company
3.4 Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Weight Loss Drugs Product Location Distribution
3.4.2 Players Long-acting Weight Loss Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Weight Loss Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting Weight Loss Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting Weight Loss Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting Weight Loss Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting Weight Loss Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting Weight Loss Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting Weight Loss Drugs Sales Growth
4.4 APAC Long-acting Weight Loss Drugs Sales Growth
4.5 Europe Long-acting Weight Loss Drugs Sales Growth
4.6 Middle East & Africa Long-acting Weight Loss Drugs Sales Growth
5 AMERICAS
5.1 Americas Long-acting Weight Loss Drugs Sales by Country
5.1.1 Americas Long-acting Weight Loss Drugs Sales by Country (2021-2026)
5.1.2 Americas Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
5.2 Americas Long-acting Weight Loss Drugs Sales by Type (2021-2026)
5.3 Americas Long-acting Weight Loss Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Weight Loss Drugs Sales by Region
6.1.1 APAC Long-acting Weight Loss Drugs Sales by Region (2021-2026)
6.1.2 APAC Long-acting Weight Loss Drugs Revenue by Region (2021-2026)
6.2 APAC Long-acting Weight Loss Drugs Sales by Type (2021-2026)
6.3 APAC Long-acting Weight Loss Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Weight Loss Drugs by Country
7.1.1 Europe Long-acting Weight Loss Drugs Sales by Country (2021-2026)
7.1.2 Europe Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
7.2 Europe Long-acting Weight Loss Drugs Sales by Type (2021-2026)
7.3 Europe Long-acting Weight Loss Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Weight Loss Drugs by Country
8.1.1 Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting Weight Loss Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs
10.3 Manufacturing Process Analysis of Long-acting Weight Loss Drugs
10.4 Industry Chain Structure of Long-acting Weight Loss Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Weight Loss Drugs Distributors
11.3 Long-acting Weight Loss Drugs Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING WEIGHT LOSS DRUGS BY GEOGRAPHIC REGION
12.1 Global Long-acting Weight Loss Drugs Market Size Forecast by Region
12.1.1 Global Long-acting Weight Loss Drugs Forecast by Region (2027-2032)
12.1.2 Global Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting Weight Loss Drugs Forecast by Type (2027-2032)
12.7 Global Long-acting Weight Loss Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.2.3 Roche Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.3.3 GSK Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Vivus
13.4.1 Vivus Company Information
13.4.2 Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.4.3 Vivus Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Vivus Main Business Overview
13.4.5 Vivus Latest Developments
13.5 Arena
13.5.1 Arena Company Information
13.5.2 Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.5.3 Arena Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Arena Main Business Overview
13.5.5 Arena Latest Developments
13.6 Orexigen
13.6.1 Orexigen Company Information
13.6.2 Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
13.6.3 Orexigen Long-acting Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Orexigen Main Business Overview
13.6.5 Orexigen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting Weight Loss Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting Weight Loss Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Orlistat
Table 4. Major Players of Semaglutide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Other
Table 7. Global Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Long-acting Weight Loss Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Long-acting Weight Loss Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Long-acting Weight Loss Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Long-acting Weight Loss Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Long-acting Weight Loss Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Long-acting Weight Loss Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Long-acting Weight Loss Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Long-acting Weight Loss Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Long-acting Weight Loss Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Long-acting Weight Loss Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution and Sales Area
Table 23. Players Long-acting Weight Loss Drugs Products Offered
Table 24. Long-acting Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Long-acting Weight Loss Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Long-acting Weight Loss Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Long-acting Weight Loss Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Long-acting Weight Loss Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Long-acting Weight Loss Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Long-acting Weight Loss Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Long-acting Weight Loss Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Long-acting Weight Loss Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Long-acting Weight Loss Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Long-acting Weight Loss Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Long-acting Weight Loss Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Long-acting Weight Loss Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Long-acting Weight Loss Drugs
Table 54. Key Market Challenges & Risks of Long-acting Weight Loss Drugs
Table 55. Key Industry Trends of Long-acting Weight Loss Drugs
Table 56. Long-acting Weight Loss Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Long-acting Weight Loss Drugs Distributors List
Table 59. Long-acting Weight Loss Drugs Customer List
Table 60. Global Long-acting Weight Loss Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Long-acting Weight Loss Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Long-acting Weight Loss Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Long-acting Weight Loss Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Long-acting Weight Loss Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Long-acting Weight Loss Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Long-acting Weight Loss Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Long-acting Weight Loss Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Long-acting Weight Loss Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Long-acting Weight Loss Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Novo Nordisk Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 76. Novo Nordisk Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Novo Nordisk Main Business
Table 78. Novo Nordisk Latest Developments
Table 79. Roche Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 81. Roche Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. GSK Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 86. GSK Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Vivus Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 91. Vivus Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Vivus Main Business
Table 93. Vivus Latest Developments
Table 94. Arena Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 96. Arena Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Arena Main Business
Table 98. Arena Latest Developments
Table 99. Orexigen Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 101. Orexigen Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Orexigen Main Business
Table 103. Orexigen Latest Developments
Table 1. Long-acting Weight Loss Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting Weight Loss Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Orlistat
Table 4. Major Players of Semaglutide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Other
Table 7. Global Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Long-acting Weight Loss Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Long-acting Weight Loss Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Long-acting Weight Loss Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Long-acting Weight Loss Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Long-acting Weight Loss Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Long-acting Weight Loss Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Long-acting Weight Loss Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Long-acting Weight Loss Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Long-acting Weight Loss Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Long-acting Weight Loss Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Long-acting Weight Loss Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Weight Loss Drugs Producing Area Distribution and Sales Area
Table 23. Players Long-acting Weight Loss Drugs Products Offered
Table 24. Long-acting Weight Loss Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Long-acting Weight Loss Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Long-acting Weight Loss Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Long-acting Weight Loss Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Long-acting Weight Loss Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Long-acting Weight Loss Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Long-acting Weight Loss Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Long-acting Weight Loss Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Long-acting Weight Loss Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Long-acting Weight Loss Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Long-acting Weight Loss Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Long-acting Weight Loss Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Long-acting Weight Loss Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Long-acting Weight Loss Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Long-acting Weight Loss Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-acting Weight Loss Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Long-acting Weight Loss Drugs
Table 54. Key Market Challenges & Risks of Long-acting Weight Loss Drugs
Table 55. Key Industry Trends of Long-acting Weight Loss Drugs
Table 56. Long-acting Weight Loss Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Long-acting Weight Loss Drugs Distributors List
Table 59. Long-acting Weight Loss Drugs Customer List
Table 60. Global Long-acting Weight Loss Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Long-acting Weight Loss Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Long-acting Weight Loss Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Long-acting Weight Loss Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Long-acting Weight Loss Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Long-acting Weight Loss Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Long-acting Weight Loss Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Long-acting Weight Loss Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Long-acting Weight Loss Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Long-acting Weight Loss Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Long-acting Weight Loss Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Novo Nordisk Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Novo Nordisk Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 76. Novo Nordisk Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Novo Nordisk Main Business
Table 78. Novo Nordisk Latest Developments
Table 79. Roche Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 81. Roche Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Roche Main Business
Table 83. Roche Latest Developments
Table 84. GSK Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 86. GSK Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. Vivus Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Vivus Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 91. Vivus Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Vivus Main Business
Table 93. Vivus Latest Developments
Table 94. Arena Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Arena Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 96. Arena Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Arena Main Business
Table 98. Arena Latest Developments
Table 99. Orexigen Basic Information, Long-acting Weight Loss Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Orexigen Long-acting Weight Loss Drugs Product Portfolios and Specifications
Table 101. Orexigen Long-acting Weight Loss Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Orexigen Main Business
Table 103. Orexigen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting Weight Loss Drugs
Figure 2. Long-acting Weight Loss Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Weight Loss Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting Weight Loss Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting Weight Loss Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2025)
Figure 10. Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Orlistat
Figure 12. Product Picture of Semaglutide
Figure 13. Product Picture of Liraglutide
Figure 14. Product Picture of Other
Figure 15. Global Long-acting Weight Loss Drugs Sales Market Share by Type in 2026
Figure 16. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Long-acting Weight Loss Drugs Consumed in Hospital
Figure 18. Global Long-acting Weight Loss Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Long-acting Weight Loss Drugs Consumed in Clinic
Figure 20. Global Long-acting Weight Loss Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Long-acting Weight Loss Drugs Consumed in Other
Figure 22. Global Long-acting Weight Loss Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Long-acting Weight Loss Drugs Sale Market Share by Application (2025)
Figure 24. Global Long-acting Weight Loss Drugs Revenue Market Share by Application in 2026
Figure 25. Long-acting Weight Loss Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Long-acting Weight Loss Drugs Sales Market Share by Company in 2026
Figure 27. Long-acting Weight Loss Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Long-acting Weight Loss Drugs Revenue Market Share by Company in 2026
Figure 29. Global Long-acting Weight Loss Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Long-acting Weight Loss Drugs Sales Market Share by Country in 2026
Figure 40. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Long-acting Weight Loss Drugs Sales Market Share by Region in 2026
Figure 48. APAC Long-acting Weight Loss Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Long-acting Weight Loss Drugs Sales Market Share by Country in 2026
Figure 59. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs in 2026
Figure 76. Manufacturing Process Analysis of Long-acting Weight Loss Drugs
Figure 77. Industry Chain Structure of Long-acting Weight Loss Drugs
Figure 78. Channels of Distribution
Figure 79. Global Long-acting Weight Loss Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-acting Weight Loss Drugs
Figure 2. Long-acting Weight Loss Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Weight Loss Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting Weight Loss Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting Weight Loss Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2025)
Figure 10. Long-acting Weight Loss Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Orlistat
Figure 12. Product Picture of Semaglutide
Figure 13. Product Picture of Liraglutide
Figure 14. Product Picture of Other
Figure 15. Global Long-acting Weight Loss Drugs Sales Market Share by Type in 2026
Figure 16. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Long-acting Weight Loss Drugs Consumed in Hospital
Figure 18. Global Long-acting Weight Loss Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Long-acting Weight Loss Drugs Consumed in Clinic
Figure 20. Global Long-acting Weight Loss Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Long-acting Weight Loss Drugs Consumed in Other
Figure 22. Global Long-acting Weight Loss Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Long-acting Weight Loss Drugs Sale Market Share by Application (2025)
Figure 24. Global Long-acting Weight Loss Drugs Revenue Market Share by Application in 2026
Figure 25. Long-acting Weight Loss Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Long-acting Weight Loss Drugs Sales Market Share by Company in 2026
Figure 27. Long-acting Weight Loss Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Long-acting Weight Loss Drugs Revenue Market Share by Company in 2026
Figure 29. Global Long-acting Weight Loss Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Long-acting Weight Loss Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Long-acting Weight Loss Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Long-acting Weight Loss Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Long-acting Weight Loss Drugs Sales Market Share by Country in 2026
Figure 40. Americas Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Long-acting Weight Loss Drugs Sales Market Share by Region in 2026
Figure 48. APAC Long-acting Weight Loss Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Long-acting Weight Loss Drugs Sales Market Share by Country in 2026
Figure 59. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Long-acting Weight Loss Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Long-acting Weight Loss Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Long-acting Weight Loss Drugs in 2026
Figure 76. Manufacturing Process Analysis of Long-acting Weight Loss Drugs
Figure 77. Industry Chain Structure of Long-acting Weight Loss Drugs
Figure 78. Channels of Distribution
Figure 79. Global Long-acting Weight Loss Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Long-acting Weight Loss Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Long-acting Weight Loss Drugs Revenue Market Share Forecast by Application (2027-2032)
